Bill Search

  • Introduced
    Mar 12, 2021
  • Passed Senate
  • Passed House
  • Signed into Law
Did you know we offer free bill tracking in Congress and 50 states, and a great mobile app? Sign up here
SR 172
Hawaii Senate Bill
REQUESTING THE DEPARTMENT OF HEALTH TO CONVENE A MEDICINAL PSILOCYBIN AND PSILOCIN WORKING GROUP TO EXAMINE THE MEDICINAL AND THERAPEUTIC EFFECTS OF PSILOCYBIN AND PSILOCIN OR DEVELOP A LONG-TERM STRATEGIC PLAN TO ENSURE THE AVAILABILITY OF MEDICINAL PSILOCYBIN AND PSILOCIN OR PSILOCYBIN-BASED AND PSILOCIN-BASED PRODUCTS THAT ARE SAFE, ACCESSIBLE, AND AFFORDABLE FOR ELIGIBLE ADULT PATIENTS.
Last Action
Senate • Jun 21, 2021: Certified copies of resolutions sent, 06-21-21.
Latest bill text
Do you support this bill?
Yay Nay

Official Summary/Bill Text

Comments on Bill

Tweets

Whip Lists

Sponsors:
Actions
  • Jun 21, 2021 | Senate
    • Certified copies of resolutions sent, 06-21-21.
  • Mar 31, 2021 | Senate
    • Report and Resolution Adopted as amended (SD 1). Aye(s) with reservations: Senator(s) Fevella. Noes, 0 (none).
  • Mar 30, 2021 | Senate
    • Reported from HTH (Stand. Com. Rep. No. 1408) with recommendation of adoption, as amended (SD 1).
    • One Day Notice 03-31-21.
  • Mar 29, 2021 | Senate
    • The committee(s) on HTH recommend(s) that the measure be PASSED, WITH AMENDMENTS. The votes in HTH were as follows: 5 Aye(s): Senator(s) Keohokalole, Baker, Moriwaki, San Buenaventura; Aye(s) with reservations: Senator(s) Fevella ; 0 No(es): none; and 0 Excused: none.
  • Mar 25, 2021 | Senate
    • The committee(s) on HTH has scheduled a public hearing on 03-29-21 1:20PM; Via Videoconference.
  • Mar 16, 2021 | Senate
    • Referred to HTH.
  • Mar 12, 2021 | Senate
    • Offered.
Documents